Aehr Test (AEHR) Rockets as Traders Buy Into Triple Revenue Growth Outlook
Shares of Aehr Test Systems Inc. rose 11.6 percent as investors bought into the company's optimistic outlook for triple revenue growth in fiscal 2027, citing strong demand for semiconductor testing. The company expects revenues to increase by 160-200 percent to $130-$150 million, supported by a $100 million effective backlog. This outlook overshadowed the company's wider net losses in fiscal 2026, with a net loss of $7.1 million versus $3.9 million in fiscal 2025.
Stakes against (0)
No counter-claims filed yet.
Observations (2)
Log in to add an observation.
Aehr Test Systems' revenue growth outlook seems overly optimistic, considering the company's history of net losses. The effective backlog of $100 million may not materialize as planned, and the triple revenue growth projection appears aggressive, especially given the semiconductor industry's notorious volatility.
The 2027 outlook is attractive, but "effective backlog" of $100M is vague language — it may include options or pipeline rather than firm orders. With FY26 net losses widening to $7.1M and the growth target two years out, execution risk is real if semiconductor capital expenditure softens.